Emergent BioSolutions Inc (EBS)
9.48
+0.08
(+0.85%)
USD |
NYSE |
Nov 22, 16:00
9.41
-0.07
(-0.74%)
After-Hours: 19:49
Emergent BioSolutions Cash from Operations (Quarterly): 153.70M for Sept. 30, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 153.70M |
| June 30, 2024 | 47.50M |
| March 31, 2024 | -62.60M |
| December 31, 2023 | 32.10M |
| September 30, 2023 | 60.00M |
| June 30, 2023 | -114.40M |
| March 31, 2023 | -184.00M |
| December 31, 2022 | 92.80M |
| September 30, 2022 | -74.00M |
| June 30, 2022 | -15.60M |
| March 31, 2022 | -37.30M |
| December 31, 2021 | 328.10M |
| September 30, 2021 | 16.70M |
| June 30, 2021 | -29.70M |
| March 31, 2021 | 5.10M |
| December 31, 2020 | 246.00M |
| September 30, 2020 | 105.20M |
| June 30, 2020 | 127.90M |
| March 31, 2020 | 57.80M |
| December 31, 2019 | 122.10M |
| September 30, 2019 | -3.10M |
| June 30, 2019 | -35.80M |
| March 31, 2019 | 104.80M |
| December 31, 2018 | -165.80M |
| September 30, 2018 | 174.00M |
| Date | Value |
|---|---|
| June 30, 2018 | 34.60M |
| March 31, 2018 | -1.00M |
| December 31, 2017 | 77.49M |
| September 30, 2017 | 34.94M |
| June 30, 2017 | 54.00M |
| March 31, 2017 | 41.67M |
| December 31, 2016 | -12.65M |
| September 30, 2016 | 27.08M |
| June 30, 2016 | -1.996M |
| March 31, 2016 | 42.17M |
| December 31, 2015 | 1.128M |
| September 30, 2015 | 104.76M |
| June 30, 2015 | 2.503M |
| March 31, 2015 | -65.87M |
| December 31, 2014 | 51.82M |
| September 30, 2014 | 78.92M |
| June 30, 2014 | 10.82M |
| March 31, 2014 | -29.24M |
| December 31, 2013 | 8.641M |
| September 30, 2013 | 60.12M |
| June 30, 2013 | 32.83M |
| March 31, 2013 | -4.626M |
| December 31, 2012 | -39.02M |
| September 30, 2012 | 46.48M |
| June 30, 2012 | 18.34M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-184.00M
Minimum
Mar 2023
328.10M
Maximum
Dec 2021
43.87M
Average
39.80M
Median
Cash from Operations (Quarterly) Benchmarks
| Geovax Labs Inc | -9.297M |
| Tonix Pharmaceuticals Holding Corp | -18.80M |
| Abbott Laboratories | 2.705B |
| Insulet Corp | 98.50M |
| SIGA Technologies Inc | -7.384M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 112.00M |
| Cash from Financing (Quarterly) | -180.30M |
| Free Cash Flow | 138.10M |
| Free Cash Flow Per Share (Quarterly) | 2.660 |
| Free Cash Flow to Equity (Quarterly) | 347.50M |
| Free Cash Flow to Firm (Quarterly) | 154.59M |
| Free Cash Flow Yield | 27.42% |